Health and Fitness Health and Fitness
Wed, March 6, 2013
[ Wed, Mar 06th 2013 ] - Market Wire
Alchemia Granted Key US Patent
Tue, March 5, 2013
Mon, March 4, 2013
Sun, March 3, 2013
Sat, March 2, 2013
Fri, March 1, 2013
Thu, February 28, 2013
Wed, February 27, 2013
Tue, February 26, 2013
Mon, February 25, 2013
Sun, February 24, 2013
Sat, February 23, 2013
Fri, February 22, 2013
Thu, February 21, 2013
[ Thu, Feb 21st 2013 ] - Market Wire
Inorganic Growth of Healthcare
Wed, February 20, 2013
Tue, February 19, 2013
Mon, February 18, 2013
Sun, February 17, 2013
Fri, February 15, 2013
Thu, February 14, 2013
Wed, February 13, 2013
Tue, February 12, 2013
Mon, February 11, 2013

Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2012 Financial Results on Thursday, March 7, 2013


//health-fitness.news-articles.net/content/2013/ .. -financial-results-on-thursday-march-7-2013.html
Published in Health and Fitness on Monday, February 25th 2013 at 3:00 GMT by Market Wire   Print publication without navigation


Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2012 Financial Results on Thursday, March 7, 2013

NANJING, China, Feb. 25, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group (NYSE: [ SCR ]), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2012 on Thursday, March 7, 2013, before the market opens in the United States. Simcere's management will host an earnings conference call on the same day at 8 a.m. ET (Thursday, March 7 at 9 p.m.Beijing/Hong Kong time).

To access the conference call, please dial:

International toll:                       

+65.6723.9381

United States toll-free:                             

+1.866.519.4004

United States toll:                         

+1.718.354.1231

China Domestic toll-free:              

800.819.0121

China Domestic mobile toll-free: 

400.620.8038

Hong Kong toll:                             

+852.2475.0994

Please ask to be connected to Q4 2012 Simcere Pharmaceutical Group Earnings Conference Call and provide the following passcode: 12783585.

Simcere will also broadcast a live audio webcast of the conference call. The broadcast will be available by visiting the "Investor Relations" section of the company's web site at [ www.simcere.com ].

Following the earnings conference call, an archive of the call will be available by dialing:

United States toll-free:              

+1.855.452.5696

United States toll:                     

+1.646.254.3697

The passcode for replay participants is 12783585. The telephone replay also will be archived on the "Investor Relations" section of the company's website for seven days following the earnings announcement.

About Simcere Pharmaceutical Group

Simcere Pharmaceutical Group (NYSE: SCR, Simcere) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, cardiovascular disease, infectious diseases and pain. For more information about Simcere Pharmaceutical Group, please visit [ www.simcere.com ].

Investor and Media Contacts:

Email: [ ir@simcere.com ]


In Nanjing:





In the United States:

Jie Liu D'Elia




Cindy Zheng


Vice President




Brunswick Group


Simcere Pharmaceutical Group



Tel: 1-212-333-3810

Tel: 86-25-8556-6666*8857














In Beijing:








Yue Yu








Brunswick Group 







Tel: 86-10-5960-8600







                                      

SOURCE Simcere Pharmaceutical Group



RELATED LINKS
[ http://www.simcere.com ]

Publication Contributing Sources